Skip to main content
. 2021 Jul 23;15(3):78. doi: 10.3892/br.2021.1454

Table IV.

Interaction of IL-6-174G/C polymorphism with clinical factors, as determined using multivariate logistic regression analysis.

Polymorphism Clinical factor IS patients, n=200 Controls, n=200 Adjusted OR (95% CI) P-value
IL-6-174G/C Hypertension        
     GG No 45 113 1.000  
     GC No 1 9 0.087 (0.009-0.797)c 0.031a
     GG Yes 145 75 4.095 (2.604-6.441)c <0.001b
     GC Yes 9 3 2.372 (0.571-9.852)c 0.235
IL-6-174G/C Hyperlipidemia        
     GG No 89 141 1.000  
     GC No 5 8 0.791 (0.219-2.852)d 0.720
     GG Yes 101 47 2.979 (1.850-4.797)d <0.001b
     GC Yes 5 4 0.705 (0.164-3.030)d 0.639
IL-6-174G/C Smoking        
     GG No 138 152 1.000  
     GC No 5 9 0.449 (0.126-1.597)e 0.216
     GG Yes 52 36 1.608 (0.929-2.784)e 0.090
     GC Yes 5 3 1.763 (0.315-9.866)e 0.519
IL-6-174G/C Alcohol drinking        
     GG No 151 164 1.000  
     GC No 5 10 0.488 (0.140-1.705)f 0.261
     GG Yes 39 24 1.968 (1.050-3.688)f 0.035a
     GC Yes 5 2 1.967 (0.317-12.193)f 0.468

aP<0.05,

bP<0.001. P-values were calculated using multivariate logistic regression analysis. The adjusted OR (95% CI) was calculated via multivariate logistic regression analysis after adjustment for

csex, age, diabetes mellitus, metabolic syndrome, hyperlipidemia, smoking and drinking;

dsex, age, diabetes mellitus, metabolic syndrome, hypertension, smoking and drinking;

esex, age, diabetes mellitus, metabolic syndrome, hypertension, hyperlipidemia and drinking;

fsex, age, diabetes mellitus, metabolic syndrome, hypertension, hyperlipidemia and smoking. IS, ischemic stroke; OR, odds ratio; CI, confidence interval.